Affects 6-12% of women of reproductive age

GLP-1 Weight Loss for PCOS

Polycystic ovary syndrome (PCOS) is a hormonal disorder affecting 6-12% of women of reproductive age, making it one of the most common causes of weight gain and difficulty losing weight in women. PCOS disrupts insulin signaling, leading to insulin resistance that promotes fat storage -- particularly around the midsection. Many women with PCOS find that traditional diets and exercise alone are not enough to achieve meaningful weight loss. The hormonal imbalances caused by PCOS create a metabolic environment where the body actively resists shedding excess weight.

GLP-1 treatment for patients with PCOS. Prescribed by licensed providers, delivered to your door. Compounded medications are not FDA-approved.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · PCOS is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated June 2026Medically reviewed by licensed providers

Semaglutide and tirzepatide are the active ingredients in FDA-approved GLP-1 medications (Wegovy®, Zepbound®) whose clinical trials of the FDA-approved brand-name products studied populations that included patients with PCOS. PCOS affects approximately Affects 6-12% of women of reproductive age of U.S. adults. Weight Method offers compounded programs starting at $199/month with virtual consultations and direct shipping. Compounded medications are not FDA-approved.

How do GLP-1 medications help with this condition?

GLP-1 receptor agonists like semaglutide and tirzepatide address the root metabolic dysfunction behind PCOS-related weight gain. These medications improve insulin sensitivity, helping your body process glucose more efficiently instead of storing it as fat. Clinical studies show that women with PCOS who take GLP-1 medications experience significant reductions in body weight, waist circumference, and androgen levels. By breaking the cycle of insulin resistance, GLP-1 therapy can also help restore regular ovulation and improve fertility outcomes for women trying to conceive.

Who qualifies for treatment?

Women with PCOS who have a BMI of 27 or higher are generally strong candidates for GLP-1 weight loss treatment. Because PCOS is closely linked to insulin resistance and metabolic dysfunction, your provider may consider you eligible even at a lower BMI if other metabolic markers are present. Weight Method's online assessment evaluates your full health profile to determine the best treatment plan.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

How It Works

1

Take the Quiz

Answer questions about your health and medical condition.

2

Virtual Consultation

A provider will review your case and create a personalized plan.

3

Get Your Medication

Your GLP-1 medication ships directly to your door.

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Yes. By improving insulin sensitivity and reducing body weight, GLP-1 medications can lower androgen levels, which may reduce acne, excess hair growth, and irregular periods. Some women also see improvements in fertility and ovulation regularity.

Clinical data suggests women with PCOS can lose 10-15% of their body weight over 12-18 months on semaglutide, though individual results vary. This is significantly more than most women with PCOS achieve through diet and exercise alone.

Treatment duration varies by individual. Some women use GLP-1 medications for 12-24 months to reach their target weight and then transition to maintenance through lifestyle changes. Your Weight Method provider will work with you to create a personalized timeline.

In many cases, yes. GLP-1 medications and metformin work through complementary mechanisms and are frequently prescribed together. Your Weight Method provider will review your current medications during your consultation to ensure safe combination therapy.

Both medications are effective for PCOS-related weight loss. Tirzepatide targets both GLP-1 and GIP receptors, which may offer additional insulin-sensitizing benefits. Your provider will recommend the best option based on your specific health profile and goals.

Most patients notice reduced appetite within the first 1-2 weeks. Measurable weight loss typically begins within the first month, with more significant results at the 3-month mark. Improvements in PCOS symptoms like menstrual regularity may take 3-6 months.

Start Your Treatment

Find out if GLP-1 medications can help you lose weight with PCOS.

Get Started Now

Free consultation. No commitment.

GLP-1 Medications

SemaglutideTirzepatideSemaglutide vs Tirzepatide

Other Conditions

Type 2 DiabetesHypothyroidismSleep ApneaHigh Blood PressureJoint Pain & ArthritisMetabolic SyndromePrediabetes

PCOS by City

PCOS in Abbeville, LAPCOS in Aberdeen, MDPCOS in Aberdeen, SDPCOS in Aberdeen, WAPCOS in Abilene, TXPCOS in Acworth, GAPCOS in Ada, OKPCOS in Addison, IL